Title page for ETD etd-06082007-164348


Document Type Doctoral Thesis
Author Prinsloo, Gerhard
Email gprinsloo@arc.agric.za
URN etd-06082007-164348
Document Title Isolation of an anti-HIV compound from Elaeodendron croceum (Thunb.) DC.
Degree PhD (Plant Physiology)
Department Botany
Supervisor
Advisor Name Title
Prof J J M Meyer
Keywords
  • an anti-HIV compound
  • Elaeodendron croceum (Thunb.) DC
  • Isolation
Date 2007-04-20
Availability unrestricted
Abstract
HIV/AIDS threaten more than 40 million people worldwide and more than 5 million in South Africa alone. There is no cure for the disease yet, and novel drugs need to be discovered to make any progress in combating the disease.

Twelve extracts from indigenous South African plants were analysed, of which one, Elaeodendron croceum, showed exceptionally good inhibition of transcription factors and a recombinant HIV strain in the HeLa-TAT-Luc and MT-2 VSV-pseudotyped recombinant virus assays. The pure compound isolated from this extract seemed to be the most toxic of all the samples, with toxicity of only 25% at a concentration of 100 _g/ml. When the concentration is increased, the toxicity increased slowly from 15% at a concentration of 0.195 _g/ml until it reached 25% toxicity at a concentration of 100 _g/ml. The active concentration of the compound against HIV is much lower at 100 ng/ml with an inhibition of approximately 90% of the recombinant virus. The therapeutic index of 250 makes it a promising possibility to be studied further for the compound to be used as a drug.

The semi-purified extract and the pure compound were tested for its toxicity on VERO cells. The semi-purified extract had no toxicity up to a concentration of 50 _g/ml and the pure compound had toxicity of 20 % up to a concentration of 25_g/ml. The active concentration of 100 ng/ml for the VSV-Pseudotype assay is much lower than the start of toxicity at 25 _g/ml, and leaves a margin of activity before the toxicity level is reached.

Both the extract and pure compound shows promising results in vitro to be developed into a medicine to be used against HIV, but need more research on the effects in vivo. Using an extract is easier, cheaper and faster than isolating a pure compound from the extract. It might also be possible that the extract could be prepared as a tea and its use could be very accessible.

Files
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  00front.pdf 81.17 Kb 00:00:22 00:00:11 00:00:10 00:00:05 < 00:00:01
  01chapter1.pdf 973.99 Kb 00:04:30 00:02:19 00:02:01 00:01:00 00:00:05
  02chapter2.pdf 594.56 Kb 00:02:45 00:01:24 00:01:14 00:00:37 00:00:03
  03chapter3.pdf 503.74 Kb 00:02:19 00:01:11 00:01:02 00:00:31 00:00:02
  04chapter4.pdf 262.33 Kb 00:01:12 00:00:37 00:00:32 00:00:16 00:00:01
  05chapter5.pdf 222.01 Kb 00:01:01 00:00:31 00:00:27 00:00:13 00:00:01
  06chapter6.pdf 212.63 Kb 00:00:59 00:00:30 00:00:26 00:00:13 00:00:01
  07chapter7.pdf 165.63 Kb 00:00:46 00:00:23 00:00:20 00:00:10 < 00:00:01
  08back.pdf 51.12 Kb 00:00:14 00:00:07 00:00:06 00:00:03 < 00:00:01

Browse All Available ETDs by ( Author | Department )

If you have more questions or technical problems, please Contact UPeTD.